Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.499.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.38NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.38NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.38NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.116NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.116NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.116NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.134NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.134NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.134NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.393NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.393NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.393NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.381NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.381NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.381NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
C.32NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
C.32NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.32NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AE.8NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AE.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AE.8NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.516NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.516NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-1906.48Singapore
B.1.1.516NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.526NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.526NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.526NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.279NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.279NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.279NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.51NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.51NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.51NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.3.18NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.3.18NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.3.18NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XATNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XATNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XATNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.24NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.24NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.24NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.3.11NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.3.11NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.3.11NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.3.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.3.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.3.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.85NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used